Tag: Nordisk
Propelled by its obesity treatments, Novo Nordisk is hot on the heels of LVMH on the stock market
(BFM Bourse) – The pharmaceutical laboratory now weighs nearly 430 billion dollars on the stock market and is getting closer to LVMH, which is currently the largest listed European company.…
Novo Nordisk: Oddo BHF raises its price target
(CercleFinance.com) – Oddo BHF maintains its outperformance rating on the Novo Nordisk share with a price target raised from 1,210 to 1,440 DKK. The analyst recalls that the laboratory yesterday…
Novo Nordisk: Conclusive trial for semaglutide
(CercleFinance.com) – Novo Nordisk today announced the main results of a trial carried out on more than 17,000 adults aged 45 or over suffering from overweight or obesity and cardiovascular…
Novo Nordisk: Weight loss drug cuts risk of heart disease by 20%
COPENHAGEN/LONDON (Reuters) – Novo Nordisk said on Tuesday its obesity drug Wegovy reduced the risk of a major cardiovascular event such as stroke by 20% in overweight or obese people…
Biocorp: takeover by Novo Nordisk completed – 08/07/2023 at 08:00
(CercleFinance.com) – Biocorp announces, following obtaining the usual regulatory authorizations, the completion of the off-market acquisition by Novo Nordisk of a total of 2,838,669 shares, i.e. 64.3% of the capital…
Biocorp: takeover by Novo Nordisk completed
(CercleFinance.com) – Biocorp announces, following obtaining the usual regulatory authorizations, the completion of the off-market acquisition by Novo Nordisk of a total of 2,838,669 shares, i.e. 64.3% of the capital…
Completion of the acquisition by Novo Nordisk of a controlling block in the capital of BIOCORP – 2023-08-04 at 18:00
Issoire (France), August 4, 2023 at 6:00 p.m. CEST – Following the announcement of the proposed acquisition of BIOCORP Production SA (FR0012788065 – ALCOR) (“BIOCORP”) by NOVO NORDISK (DK0060534915 –…
Acquisition by Novo Nordisk of a controlling block in the capital of Biocorp
(AOF) – Following the announcement of the proposed acquisition of Biocorp by Novo Nordisk (a leading global company in the field of health care, Biocorp announces, following the obtaining of…
Acquisition by Novo Nordisk of a controlling stake in the capital of Biocorp – 08/04/2023 at 18:14
(AOF) – Following the announcement of the proposed acquisition of Biocorp by Novo Nordisk (a leading global company in the field of health care, Biocorp announces, following the obtaining of…
Novo Nordisk: Acquisition of a control block in Biocorp
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Acquisition of Biocorp by Novo Nordisk approved – 06/19/2023 at 08:40
(AOF) – Following the announcement on June 5 of the proposed acquisition of Biocorp by Novo Nordisk, a leading global healthcare company headquartered in Denmark that develops treatments for diabetes…
Novo Nordisk: acquisition of a control block in Biocorp
(CercleFinance.com) – Biocorp announces the signing of a contract for the sale by its main shareholder BIO JAG, of 1,998,800 shares (i.e. 45.3% of the capital and 62.2% of the…